The global macroeconomic burden of diabetes mellitus

21089 6 112205 2 338852 document 112205 s41591-025-04027-5.pdf application/pdf 15230b507d490bd2f60c569a0a34a6a7 MD5 4001599 2026-01-07 09:23:32 https://pure.iiasa.ac.at/id/eprint/21089/1/s41591-025-04027-5.pdf 21089 1 1 application/pdf text en public cc_by_4

s41591-025-04027-5.pdf

published 112216 1 338869 document 112216 indexcodes.txt text/x-c 9c64f8b18d7506f0e60b83667870dfe7 MD5 19854 2026-01-07 09:33:49 https://pure.iiasa.ac.at/id/eprint/21089/2/indexcodes.txt 21089 2 2 text/x-c other Generate index codes conversion from text to indexcodes en public

indexcodes.txt

lightbox.jpg

preview.jpg

medium.jpg

small.jpg

http://eprints.org/relation/isVersionOf https://pure.iiasa.ac.at/id/document/112205 http://eprints.org/relation/isVolatileVersionOf https://pure.iiasa.ac.at/id/document/112205 http://eprints.org/relation/issmallThumbnailVersionOf https://pure.iiasa.ac.at/id/document/112205 archive 353 disk0/00/02/10/89 2026-01-07 09:24:52 2026-01-07 09:24:52 2026-01-07 09:24:52 article show Chen S. Cao Z. Chen W. Zhao J. Jiao L. Prettner K. Kuhn M. 2235 Pan A. Bärnighausen T.W. Bloom D.E. The global macroeconomic burden of diabetes mellitus pub EF Diabetes mellitus poses a substantial and rising global health and economic burden, affecting more than one in ten adults worldwide. Using a health-augmented macroeconomic model across 204 countries and territories, we estimated the economic impact of diabetes from 2020 to 2050, incorporating losses in effective labor supply due to mortality and morbidity, treatment-related resource diversion and informal caregiving costs. Without informal care, the global burden amounts to $10.2 trillion (2017 international dollars (INT$)), equivalent to 0.22% of annual global gross domestic product. Including informal care, the burden increases dramatically to INT$78.8 trillion, ranging from INT$5.5 trillion to INT$152.1 trillion, depending on the assumptions for care. The absolute costs are highest in the United States, China and India, while relative and per capita burdens are greatest in countries such as American Samoa and Australia. These findings highlight the uneven distribution of diabetes’ economic impact and underscore the urgent need for effective global interventions. 2025-12-29 published Nature Publishing Group doi:10.1038/s41591-025-04027-5 3124 public Nature Medicine TRUE 1078-8956 info:eu-repo/semantics/article